Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03568994
Title Atovaquone (Mepron) Combined With Conventional Chemotherapy for de Novo Acute Myeloid Leukemia (AML)
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Baylor College of Medicine
Indications

acute myeloid leukemia

Therapies

Atovaquone + Cytarabine + Daunorubicin + Etoposide

Atovaquone + Cytarabine + Daunorubicin + Gemtuzumab ozogamicin

Age Groups: adult | child
Covered Countries USA


No variant requirements are available.